SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-002734
Filing Date
2019-03-01
Accepted
2019-03-01 06:16:09
Documents
32
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 243635
2 ex31-1.htm EX-31.1 18267
3 ex31-2.htm EX-31.2 18647
4 ex32-1.htm EX-32.1 6925
5 ex32-2.htm EX-32.1 6851
  Complete submission text file 0001493152-19-002734.txt   1089014

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prtt-20180331.xml EX-101.INS 77943
7 XBRL SCHEMA FILE prtt-20180331.xsd EX-101.SCH 13720
8 XBRL CALCULATION FILE prtt-20180331_cal.xml EX-101.CAL 20658
9 XBRL DEFINITION FILE prtt-20180331_def.xml EX-101.DEF 44885
10 XBRL LABEL FILE prtt-20180331_lab.xml EX-101.LAB 111139
11 XBRL PRESENTATION FILE prtt-20180331_pre.xml EX-101.PRE 80729
Mailing Address 4876 CECILE AVENUE LAS VEGAS NV 89115
Business Address 4876 CECILE AVENUE LAS VEGAS NV 89115 954-292-0033
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

IRS No.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54001 | Film No.: 19646608
SIC: 2834 Pharmaceutical Preparations